| A4 | 4-androstenedione |
| ABP | androgen-binding protein |
| AcT | * acyl-testosterone |
| ACTH | corticotropin-[adrenocorticotropic] hormone |
| Ane | * androsterone [5α-androsterone] |
| AP | * ∆16–17-androgenic pheromones |
| AR | androgen receptor |
| ARE | androgen response element |
| CRH | corticotropin-releasing hormone |
| DHEA | dehydroepiandrosterone |
| DHEAS | dehydroepiandrosterone-sulfate |
| DHT | dihydrotestosterone |
| E1 | estrone |
| E2 | estradiol [17β-estradiol] |
| EA | * estrogenic androgens |
| ER | estrogen receptor |
| FSH | follicle-stimulating hormone |
| GC | glucocorticoid(s) |
| GH | growth hormone |
| GnIH | gonadotropin-inhibitory hormone |
| GnRH | gonadotropin-releasing hormone |
| GR | glucocorticoid receptor |
| HHA | hypothalamus–hypophysis–adrenals (axis) |
| HHG | hypothalamus–hypophysis–gonads (axis) |
| KT | * 11-keto-testosterone |
| KTs | * 11-oxo-androgens in general |
| LH | luteotropic hormone |
| MS | * metabolic syndrome |
| POCS | polycystic ovary syndrome |
| SARM | selective AR modulator |
| SERM | selective ER modulator |
| SHBG | sex-hormone binding globulin |
| T | testosterone |
| TAG | triacyl-glycerol(s) |
| TRP | transient receptor protein |
| TRT | testosterone-replacement therapy |
| 11βHSDH | 11β-hydroxysteroid dehydrogenase |
| * non-standard abbreviations/acronyms. | |